As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
Here’s how you can use AI as a decision-making partner so you can think better, personalize at scale and operate like a larger team without losing your voice.
AI’s early-2025 spending spree featured massive raises and trillion-dollar infrastructure promises. By year’s end, hype gave way to a vibe check, with growing scrutiny over sustainability, safety, and business models.
The electrical grid is facing unprecedented stress from the addition of new data centers. Software could offer a cost-effective way to boost reliability and capacity.